Immune Repertoire Sequencing Market Segmented By TCR Kits, BCR Kits as Assay Kits and Analytical Software, Sequencing Services, Data Analysis Services as Software and Services for Biomarker Discovery, Vaccine Development and efficacy, Infectious Diseases, Cancer Immunotherapy, Autoimmune Disease, Transplant Rejection and Tolerance
Industry: Healthcare
Published Date: October-2018
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 219
Report ID: PMRREP14911
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Immune Repertoire Sequencing Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunity
4.1.4. Trends
5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2006 - 2021
5.2. Global Healthcare Market Outlook
6. Key Inclusions
6.1. Product Mapping
6.2. Key Developments
6.3. Regional Average Pricing Analysis (2017)
7. North America Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026
7.1. Introduction
7.2. Historical Market Value (US$ Mn) Trend Analysis By Country, 2013-2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Value (US$ Mn) Forecast By Country, 2018-2026
7.4. Historical Market Value (US$ Mn) and By Component, 2012-2016
7.4.1. Assay Kits
7.4.1.1. TCR Kits
7.4.1.2. BCR Kits
7.4.2. Software & Services
7.4.2.1. Analytical Software
7.4.2.2. Sequencing Services
7.4.2.3. Data Analysis Services
7.5. Market Value (US$ Mn) and Forecast By Component, 2018-2026
7.6. Historical Market Value(US$ Mn) By Application, 2012-2016
7.6.1. Biomarker Discovery
7.6.2. Infectious Diseases
7.6.3. Vaccine Development and efficacy
7.6.4. Cancer Immunotherapy
7.6.5. Autoimmune Disease
7.6.6. Transplant Rejection and Tolerance
7.6.7. Others
7.7. Market Value (US$ Mn) Forecast By Application, 2018-2026
7.8. Historical Market Value (US$ Mn) By End user, 2012-2016
7.8.1. Academic Institutes
7.8.2. Research Centers
7.9. Market Value (US$ Mn) Forecast By End user,2018-2026
7.10. Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Component
7.10.3. By Application
7.10.4. By End user
7.11. Drivers and Restraints: Impact Analysis
8. Latin America Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026
8.1. Introduction
8.2. Key Regulations
8.3. Regional Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Trends
8.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
8.4.1. Brazil
8.4.2. Mexico
8.4.3. Rest of Latin America
8.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
8.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
8.6.1. Assay Kits
8.6.1.1. TCR Kits
8.6.1.2. BCR Kits
8.6.2. Software & Services
8.6.2.1. Analytical Software
8.6.2.2. Sequencing Services
8.6.2.3. Data Analysis Services
8.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
8.8. Historical Market Value (US$ Mn) By Application, 2012-2016
8.8.1. Biomarker Discovery
8.8.2. Infectious Diseases
8.8.3. Vaccine Development and efficacy
8.8.4. Cancer Immunotherapy
8.8.5. Autoimmune Disease
8.8.6. Transplant Rejection and Tolerance
8.8.7. Others
8.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
8.10. Historical Market Value (US$ Mn) By End user, 2012-2016
8.10.1. Academic Institutes
8.10.2. Research Centers
8.11. Market Value (US$ Mn) Forecast By End user, 2018-2026
8.12. Market Attractiveness Analysis
8.12.1. By Country
8.12.2. By Component
8.12.3. By Application
8.12.4. By End user
8.13. Drivers and Restraints: Impact Analysis
9. Europe Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026
9.1. Introduction
9.2. Key Regulations
9.3. Regional Market Dynamics
9.3.1. Drivers
9.3.2. Restraints
9.3.3. Trends
9.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Poland
9.4.7. Russia
9.4.8. Rest of Europe
9.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
9.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
9.6.1. Assay Kits
9.6.1.1. TCR Kits
9.6.1.2. BCR Kits
9.6.2. Software & Services
9.6.2.1. Analytical Software
9.6.2.2. Sequencing Services
9.6.2.3. Data Analysis Services
9.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
9.8. Historical Market Value(US$ Mn) By Application, 2012-2016
9.8.1. Biomarker Discovery
9.8.2. Infectious Diseases
9.8.3. Vaccine Development and efficacy
9.8.4. Cancer Immunotherapy
9.8.5. Autoimmune Disease
9.8.6. Transplant Rejection and Tolerance
9.8.7. Others
9.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
9.10. Historical Market Value (US$ Mn) By End user, 2012-2016
9.10.1. Academic Institutes
9.10.2. Research Centers
9.11. Market Value (US$ Mn) Forecast By End user, 2018-2026
9.12. Market Attractiveness Analysis
9.12.1. By Country
9.12.2. By Component
9.12.3. By Application
9.12.4. By End user
9.13. Drivers and Restraints: Impact Analysis
10. Asia Pacific (APAC) Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026
10.1. Introduction
10.2. Key Regulations
10.3. Regional Market Dynamics
10.3.1. Drivers
10.3.2. Restraints
10.3.3. Trends
10.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. Australia and New Zealand
10.4.5. Rest of APAC
10.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
10.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
10.6.1. Assay Kits
10.6.1.1. TCR Kits
10.6.1.2. BCR Kits
10.6.2. Software & Services
10.6.2.1. Analytical Software
10.6.2.2. Sequencing Services
10.6.2.3. Data Analysis Services
10.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
10.8. Historical Market Value (US$ Mn) By Application, 2012-2016
10.8.1. Biomarker Discovery
10.8.2. Infectious Diseases
10.8.3. Vaccine Development and efficacy
10.8.4. Cancer Immunotherapy
10.8.5. Autoimmune Disease
10.8.6. Transplant Rejection and Tolerance
10.8.7. Others
10.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
10.10. Historical Market Value (US$ Mn) By End user, 2012-2016
10.10.1. Academic Institutes
10.10.2. Research Centers
10.11. Market Value (US$ Mn) Forecast By End user,2018-2026
10.12. Market Attractiveness Analysis
10.12.1. By Country
10.12.2. By Component
10.12.3. By Application
10.12.4. By End user
10.13. Drivers and Restraints: Impact Analysis
11. Middle East and Africa (MEA) Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026
11.1. Introduction
11.2. Key Regulations
11.3. Regional Market Dynamics
11.3.1. Drivers
11.3.2. Restraints
11.3.3. Trends
11.4. Historical Market Size (US$ Mn) and By Country, 2012-2016
11.4.1. GCC Countries
11.4.2. South Africa
11.4.3. Rest of MEA
11.5. Market Size (US$ Mn) and Forecast By Country, 2018-2026
11.6. Historical Market Value (US$ Mn) and By Component, 2012-2016
11.6.1. Assay Kits
11.6.1.1. TCR Kits
11.6.1.2. BCR Kits
11.6.2. Software & Services
11.6.2.1. Analytical Software
11.6.2.2. Sequencing Services
11.6.2.3. Data Analysis Services
11.7. Market Value (US$ Mn) and Forecast By Component, 2018-2026
11.8. Historical Market Value(US$ Mn) By Application, 2012-2016
11.8.1. Biomarker Discovery
11.8.2. Infectious Diseases
11.8.3. Vaccine Development and efficacy
11.8.4. Cancer Immunotherapy
11.8.5. Autoimmune Disease
11.8.6. Transplant Rejection and Tolerance
11.8.7. Others
11.9. Market Value (US$ Mn) Forecast By Application, 2018-2026
11.10. Historical Market Value (US$ Mn) By End user, 2012-2016
11.10.1. Academic Institutes
11.10.2. Research Centers
11.11. Market Value (US$ Mn) Forecast By End user,2018-2026
11.12. Market Attractiveness Analysis
11.12.1. By Country
11.12.2. By Component
11.12.3. By Application
11.12.4. By End user
11.13. Drivers and Restraints: Impact Analysis
12. Forecast Factors: Relevance and Impact
13. Market Structure Analysis
13.1. Market Structure by Tier Companies
13.2. Competition Dashboard
13.3. Market Share Analysis (2017) by Global level
14. Competition Profile
14.1. Company Deep Dive
14.1.1. Illumina, Inc.
14.1.1.1. Overview
14.1.1.2. Key Financials
14.1.1.3. Product and Application Portfolio
14.1.1.4. Key Developments
14.1.1.5. Strategy
14.1.1.5.1. Marketing Strategy
14.1.1.5.2. Product Strategy
14.1.1.5.3. Channel Strategy
14.1.2. Pacific Biosciences of California, Inc
14.1.2.1. Overview
14.1.2.2. Key Financials
14.1.2.3. Product and Application Portfolio
14.1.2.4. Key Developments
14.1.2.5. Strategy
14.1.2.5.1. Marketing Strategy
14.1.2.5.2. Product Strategy
14.1.2.5.3. Channel Strategy
14.1.3. Agilent Technologies, Inc
14.1.3.1. Overview
14.1.3.2. Key Financials
14.1.3.3. Product and Application Portfolio
14.1.3.4. Key Developments
14.1.3.5. Strategy
14.1.3.5.1. Marketing Strategy
14.1.3.5.2. Product Strategy
14.1.3.5.3. Channel Strategy
14.1.4. Oxford Nanopore Technologies, Ltd
14.1.4.1. Overview
14.1.4.2. Product and Application Portfolio
14.1.4.3. Key Developments
14.1.4.4. Strategy
14.1.4.4.1. Marketing Strategy
14.1.4.4.2. Product Strategy
14.1.4.4.3. Channel Strategy
14.1.5. QIAGEN N.V.
14.1.5.1. Overview
14.1.5.2. Key Financials
14.1.5.3. Product and Application Portfolio
14.1.5.4. Key Developments
14.1.5.5. Strategy
14.1.5.5.1. Marketing Strategy
14.1.5.5.2. Product Strategy
14.1.5.5.3. Channel Strategy
14.1.6. Thermo Fisher Scientific
14.1.6.1. Overview
14.1.6.2. Key Financials
14.1.6.3. Product and Application Portfolio
14.1.6.4. Key Developments
14.1.6.5. Strategy
14.1.6.5.1. Marketing Strategy
14.1.6.5.2. Product Strategy
14.1.6.5.3. Channel Strategy
14.1.7. F. Hoffmann-La Roche Ltd
14.1.7.1. Overview
14.1.7.2. Key Financials
14.1.7.3. Product and Application Portfolio
14.1.7.4. Key Developments
14.1.7.5. Strategy
14.1.7.5.1. Marketing Strategy
14.1.7.5.2. Product Strategy
14.1.7.5.3. Channel Strategy
14.1.7.5.4. Channel Strategy
14.1.8. BGI
14.1.8.1. Overview
14.1.8.2. Key Financials
14.1.8.3. Product and Application Portfolio
14.1.8.4. Key Developments
14.1.8.5. Strategy
14.1.8.4.1. Marketing Strategy
14.1.8.4.2. Product Strategy
14.1.8.4.3. Channel Strategy
14.1.8.4.4. Channel Strategy
14.1.9. Takara Bio, Inc
14.1.9.1. Overview
14.1.9.2. Key Financials
14.1.9.3. Product and Application Portfolio
14.1.9.4. Key Developments
14.1.9.5. Strategy
14.1.9.5.1. Marketing Strategy
14.1.9.5.2. Product Strategy
14.1.9.5.3. Channel Strategy
14.1.9.5.4. Channel Strategy
15. Global Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026, By Region
15.1. Introduction
15.1.1. Basis Point Share (BPS) Analysis By Region
15.1.2. Y-o-Y Growth Projections By Region
15.2. Historical Market Value Analysis 2013-2017, By Region
15.2.1. North America
15.2.2. Latin America
15.2.3. Europe
15.2.4. Asia Pacific (APAC)
15.2.5. Middle East and Africa (MEA)
15.3. Market Value Analysis 2018-2026, By Region
15.3.1. North America
15.3.2. Latin America
15.3.3. Europe
15.3.4. Asia Pacific (APAC)
15.3.5. Middle East and Africa (MEA)
15.4. Market Attractiveness Analysis By Region
16. Global Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026, By Component
16.1. Introduction
16.1.1. Basis Point Share (BPS) Analysis By Component
16.1.2. Y-o-Y Growth Projections By Component
16.2. Historical Market Value Analysis 2013-2017, By Component
16.2.1. Assay Kits
16.2.1.1. TCR Kits
16.2.1.2. BCR Kits
16.2.2. Software & Services
16.2.2.1. Analytical Software
16.2.2.2. Sequencing Services
16.2.2.3. Data Analysis Services
16.3. Market Value Analysis 2017-2015, By Component
16.4. Market Attractiveness Analysis By Component
17. Global Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026, By Applications
17.1. Introduction
17.1.1. Basis Point Share (BPS) Analysis By Applications
17.1.2. Y-o-Y Growth Projections By Applications
17.2. Historical Market Value Analysis 2013-2017, By Applications
17.2.1. Biomarker Discovery
17.2.2. Infectious Diseases
17.2.3. Vaccine Development and efficacy
17.2.4. Cancer Immunotherapy
17.2.5. Autoimmune Disease
17.2.6. Transplant Rejection and Tolerance
17.2.7. Others
17.3. Historical Market Value Analysis 2018-2026, By Applications
17.4. Market Attractiveness Analysis By Applications
18. Global Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2018-2026, By End User
18.1. Introduction
18.1.1. Basis Point Share (BPS) Analysis By End User
18.1.2. Y-o-Y Growth Projections By End User
18.2. Historical Market Value Analysis 2013-2017, By End User
18.2.1. Academic Institutes
18.2.2. Research Centers
18.3. Market Value Analysis 2018-2026, By End User
18.4. Market Attractiveness Analysis By End User
19. Global Immune Repertoire Sequencing Market Analysis 2013-2017 and Forecast 2017-2026
19.1. Market Size and Y-o-Y Growth
19.2. Absolute $ Opportunity
20. Assumptions and Acronyms Used
21. Research Methodology
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: Assay Kits Product Mapping
Table 04: Assay Kits Product Mapping
Table 05: Software Services Product Mapping
Table 06: Software Services Product Mapping
Table 07: Software Services Product Mapping
Table 08: Software & Services Product Mapping
Table 09: Software & Services Product Mapping
Table 10: Key Developments
Table 11: Key Developments
Table 12: North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 13: North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
Table 14: North America Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 15: North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 16: Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 17: Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
Table 18: Latin America Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 19: Latin America Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 20: Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 21: Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
Table 22: Europe Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 23: Europe Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 24: Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 25: Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
Table 26: Asia Pacific Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 27: Asia Pacific Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 28: Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 29: Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Component
Table 30: Middle East & Africa Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By Application
Table 31: Middle East & Africa Immune Repertoire Sequencing Market Size Analysis 2013-2017 and Forecast 2018-2026, By End User
Table 32: Global Immune Repertoire Sequencing Market Size (US$ Mn) 2013-2017 and Forecast 2018-2026 By Region
Table 33: Global Market Size (US$ Mn) 2013-2017 and Forecast 2018-2026 By Component
Table 34: Global Market Size (US$ Mn) 2013-2017 and Forecast 2018-2026 By Application
Table 35: Global Market Size (US$ Mn) 2013-2017 and Forecast 2018-2026 By End User
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: Global Healthcare Expenditure in US$ Tn (2013-2020)
Figure 02: Regional Average Pricing Analysis (US$) of Assay Kits (2017)
Figure 03: Regional Average Pricing Analysis (US$) of Assay Kits s (2026)
Figure 04: Regional Average Pricing Analysis (US$) Software & Services (2017)
Figure 05: Regional Average Pricing Analysis (US$) Software & Services (2026)
Figure 06: North America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 07: North America Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 08: U.S. Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 09: U.S. Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 10: Canada Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 11: Canada Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 12: Assay Kits Market Size (US$ Mn) Analysis, 2013-2017
Figure 13: Assay Kits Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 14: Software Service Market Size (US$ Mn) Analysis, 2013-2017
Figure 15: Software Service Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 16: North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
Figure 17: North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
Figure 18: North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
Figure 19: North America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
Figure 20: Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 21: Latin America Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 22: Brazil Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 23: Brazil Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 24: Mexico Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 25: Mexico Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 26: Rest of Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 27: Rest of Latin America Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 28: Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
Figure 29: Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
Figure 30: Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
Figure 31: Latin America Medical immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
Figure 32: Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 33: Europe Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 34: Germany Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 35: Germany Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 36: U.K Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 37: U.K. Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 38: France Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 39: France Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 40: Spain Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 41: Spain Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 42: Italy Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 43: Italy Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 44: Russia Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 45: Russia Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 46: Poland Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 47: Poland Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 48: Rest of Europe Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 49: Rest of Europe Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 50: Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
Figure 51: Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
Figure 52: Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
Figure 53: Europe immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
Figure 54: Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 55: Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 56: India Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 57: India Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 58: Aus & NZ Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 59: Aus & NZ . Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 60: China Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 61: China Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 62: Japan Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 63: Japan Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 64: Rest of Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 65: Rest of Asia Pacific Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 66: Asia Pacific immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
Figure 67: Asia Pacific immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
Figure 68: Asia Pacific repertoire sequencing Detectors Market Attractiveness Analysis, By End User
Figure 69: Asia Pacific repertoire sequencing Detectors Market Attractiveness Analysis, By Country
Figure 70: MEA Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 71: MEA Immune Repertoire Sequencing Market Size (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 72: GCC Countries Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 73: GCC Countries Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 74: South Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 75: South Africa Immune Repertoire Sequencing Market Value (US$ Mn) & Y-o-Y Growth (%), 2018-2026
Figure 76: Rest of Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 77: Rest of Middle East & Africa Immune Repertoire Sequencing Market Size (US$ Mn) Analysis, 2013-2017
Figure 78: Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By Component
Figure 79: Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By Application
Figure 80: Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By End User
Figure 81: Middle East & Africa immune repertoire sequencing Detectors Market Attractiveness Analysis, By Country
Figure 82: Global Immune Repertoire Sequencing Market Share Analysis (%) By Region, 2018 & 2026
Figure 83: Global Immune Repertoire Sequencing Market Y-o-Y Growth (%) By Region, 2017-2026
Figure 84: Global Immune Repertoire Sequencing Market Attractiveness Analysis By Region, 2018-2026
Figure 85: Global Market Share Analysis (%) By Component, 2018 & 2026
Figure 86: Global Market Y-o-Y Growth (%) By Component, 2017-2026
Figure 87: Global Market Attractiveness Analysis Component, 2018-2026
Figure 88: Global Market Share Analysis (%) By Application , 2018 & 2026
Figure 89: Global Market Y-o-Y Growth (%) By Application, 2017-2026
Figure 90: Global Market Attractiveness Analysis By Application, 2018-2026
Figure 91: Global Market Share Analysis (%) By End User , 2018 & 2026
Figure 92: Global Market Y-o-Y Growth (%) By End User, 2017-2026
Figure 93: Global Market Attractiveness Analysis By End User, 2018-2026
Figure 94: Global Immune Repertoire Sequencing Market Value Analysis and Forecast, 2017-2026 (US$ Mn)
Figure 95: Global Immune Repertoire Sequencing Market Absolute $ Opportunity (US$ Mn), 2017-2026
